Company highlights durable long-term survival in Expanded Access Program (EAP) cohort supporting Phase 3b patient selection and inclusion criteria NEW YORK, March 31, 2026 /PRNewswire/ -- BrainStorm ...

Dustin Poirier officially called time on his fighting career after dropping a decision loss to Max Holloway in their trilogy bout at UFC 318. He left his gloves in the center of the octagon and is ...

Google released emergency updates to fix another Chrome zero-day vulnerability exploited in attacks, marking the fourth such security flaw patched since the start of the year. "Google is aware that an ...

Often diagnosed when surgery is no longer an option, pancreatic cancer is one of the most difficult cancers to treat and has one of the lowest rates of survival among major malignancies. Like many ...

Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company, announces it has entered into an agreement to out-license its MK Cell patents to Pleiades Pharma Ltd ("Pleiades") in return ...

Read the latest healthcare, biotech, and pharmaceutical stock news and analysis. Uncover the latest research and company analysis to empower your investments.

This live page is now closed. You can continue to follow our coverage here.